Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance

Br J Clin Pharmacol. 2022 May;88(5):2441-2443. doi: 10.1111/bcp.15129. Epub 2021 Nov 7.

Authors

Eugenia Gallo¹, Valentina Maggini¹, Niccolò Lombardi^{2

3}, Giada Crescioli^{2

3}, Francesco Sivelli¹, Alfredo Vannacci^{2

3}, Fabio Firenzuoli¹

Affiliations

¹ CERFIT, Research and Innovation Center in Phytotherapy and Integrated Medicine, Careggi University Hospital, Florence, Italy.
² Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.
³ Tuscan Regional Centre of Pharmacovigilance, Tuscany Region, Florence, Italy.

PMID: 34747053
DOI: 10.1111/bcp.15129

No abstract available

Publication types

Letter
Comment

MeSH terms

Erectile Dysfunction* / diagnosis
Humans
Male
Phytotherapy / adverse effects
Plant Extracts / adverse effects
Prostatic Hyperplasia* / drug therapy
Serenoa

Substances

Plant Extracts